• Users Online: 533
  • Home
  • Print this page
  • Email this page

   Table of Contents      
CASE REPORT
Year : 2020  |  Volume : 68  |  Issue : 6  |  Page : 1193-1196

Successful management of persistent macular hole after macular hole surgery with intravitreal triamcinolone acetonide: A case report


1 Department of Vitreo-Retina, Sadguru Netra Chikitsalaya, Chitrakoot, Madhya Pradesh, India
2 Department of Ophthalmology, Indraprastha Apollo Hospital and Center for Sight, New Delhi, India

Date of Submission18-Aug-2019
Date of Acceptance24-Dec-2019
Date of Web Publication25-May-2020

Correspondence Address:
Dr. Gaurav M Kohli
Department of Vitreo-Retina, Sadguru Netra Chikitsalaya, Chitrakoot - 210 204, Madhya Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1511_19

Rights and Permissions
  Abstract 


We present a case of persistent macular hole (MH) having an apical diameter of 140 microns and a basal diameter of 530 microns following a combined phacoemulsification and MH surgery. Considering post-operative cystoid macular edema (CME) as the possible reason for the failure of the initial surgery, a trial of IVTA was given. The synergistic effect of mechanical plugging of the hole by TA, coupled with resolution of cystoid changes and falling back of the macular hole resulted in the successful closure of the persistent macular hole with improvement in vision from 20/250 to 20/63.

Keywords: Cystoid macular edema, intravitreal triamcinolone acetonide, persistent macular hole


How to cite this article:
Sen AC, Kohli GM, Mitra A, Talwar D. Successful management of persistent macular hole after macular hole surgery with intravitreal triamcinolone acetonide: A case report. Indian J Ophthalmol 2020;68:1193-6

How to cite this URL:
Sen AC, Kohli GM, Mitra A, Talwar D. Successful management of persistent macular hole after macular hole surgery with intravitreal triamcinolone acetonide: A case report. Indian J Ophthalmol [serial online] 2020 [cited 2022 Nov 29];68:1193-6. Available from: https://www.ijo.in/text.asp?2020/68/6/1193/284798



The incidence of persistent macular hole (MH) following surgery with internal limiting membrane (ILM) peeling is estimated to be around 10–12%.[1]

There exists no consensus on time and type of re-surgery in cases of persistent MH. The re-intervention protocols include 1) reinjection of gas tamponade,[2] 2) extension of ILM peel,[3] 3) transplantation of a translocated ILM flap,[4] 4) and the use of adjuvants like autologous serum or blood to plug the hole. The success rate, for these invasive procedures, yet remains variable. Herein, we present a case of persistent idiopathic MH successfully managed with intravitreal triamcinolone injection and discuss the mechanism of closure.


  Case Report Top


A 63-year-old male reported to us for failure to improved vision in the left eye (LE) after a combined cataract and MH surgery at a regional specialty center 3 months ago. The patient was diagnosed to have grade 2 nuclear sclerosis with idiopathic MH, for which he underwent phacoemulsification with posterior chamber intraocular lens (PC-IOL) implantation and pars plana vitrectomy (PPV) with ILM peel. Perfluoro propane (C 3 F 8) 14% was used as a tamponading agent.

Following the primary surgery, the MH had failed to close [Figure 1]a and [Figure 1]b, hence a second surgical intervention was advised by the primary surgeon. The patient on presentation to us had a CDVA of 5/60 in LE. The slit-lamp examination revealed a quiet anterior chamber with a well-centered PC-IOL. A full-thickness MH was seen on fundus examination. The apical diameter of the hole as measured by OCT was 140 μm while the basal diameter was 530 μm. The surrounding retina showed thickening with cystic changes involving the inner retinal layers [Figure 1]c. A diagnosis of persistent MH with cystoid macular edema (CME) was made, and the patient was advised to undergo fluid-air exchange with gas tamponade.
Figure 1: (a) Preoperative OCT scans show the presence of a full-thickness neurosensory defect at the macula with a separated hyoid face (*), there is the presence of cystic changes involving the margins of dehiscence (**), (b) The postoperative OCT 2 months after surgery shows the persistence of full-thickness defect at the macula along with cystoid changes (*), (c) The pre-injection OCT scan is suggestive of the persistent macular hole with swollen photoreceptor outer segments (*), (d) The postinjection (day-1) comparative OCT scan shows triamcinolone deposits plugging the macular hole is seen as a hyper-reflective plaque with optical back shadowing (*), there is a considerable reduction in intraretinal cystic changes (**) and retinal thickness

Click here to view


However, on the patient's refusal for further surgical intervention we offered a trial of intravitreal steroid keeping in mind the possibility of post-operative CME as a contributory factor impending closure of the MH. The patient consented for the same and was injected with preservative-free IVTA 4 mg in 0.1 mL (Aurocort © Aurolab, Madurai, India).

On the first day, following the injection, the triamcinolone particulate matter was seen plugging the MH and bridging the retinal defect. The OCT showed an evident reduction in the intraretinal cystic spaces and edema [Figure 1]d.

On the first follow-up visit at one week, the CDVA had improved to 6/24. Clinical examination revealed a blunted foveal reflex with no apparent dehiscence. OCT examination showed a foveolar detachment with opposed inner retinal layers and restoration of the foveal contour. The triamcinolone particles were evident as a hyperreflective plaque filling the foveal defect on OCT [Figure 2]b.
Figure 2: (a and b) serial OCT of the fovea at day 1 post-IVTA (a) and at 1 week following injection (b) show marked reduction in retinal thickness with near normalization of the foveal contour. The margins of the dehiscence get apposed with the resolution of edema, the draw bridge effects by the approximating margins is shown to close the defect (*). The macular hole appears closed with apposed inner retinal layers albeit a small persisting foveolar detachment exists (→). TA is evident as a hyper-reflective plaque at the foveal center (*). (b) OCT did 4 months after IVTA injection shows the closure of macular hole with a very small persisting foveolar detachment (→)

Click here to view


At 1 month follow-up, the CDVA had improved further to 6/18 and was maintained at 4 months also. The CDVA remained stable at 6/18 closed MH a small persistent foveolar detachment. The TA crystals had absorbed by this time [Figure 2]c and [Figure 3].
Figure 3: (a) The postinjection fundus photo shows triamcinolone crystals deposited over the disc and plugging the foveal defect seen as a white plaque. (b) At 1 month the macular hole appears closed with the resolution of triamcinolone

Click here to view



  Discussion Top


Persistence of MH or its recurrence following successful closure has been reported in 10–12% of patients.[1] The postulated reasons for persistent MH include 1) persistent tangential; 2) suboptimal volume or duration of tamponade, and 3) postoperative inflammation-driven CME. These factors either independently or cumulatively may contribute towards the failure of MH surgery.[5]

The management strategies adopted for such failures are aimed at attending the precipitating factors: (1) reinjection of the tamponade, (2) extension of ILM peel or free ILM flap to plug the hole, (3) injection of autologous serum or blood to mechanically plug the defect. Steroids have seldom been used for the management of persistent MH. However, anecdotal reports do provide evidence of the possible role of steroids in cases of persistent MH associated with macular edema.

Yoon et al.[6] reported successful closure of a full-thickness MH within 2 weeks which remained stable even after 6 months. The MH had developed 4 weeks after PPV for vitreous hemorrhage. They attributed the hole formation to macular edema and the reduction of macular edema with IVTA which was helpful in attaining closure.

Similarly, Shukla et al.[7] reported a successful closure of MH in a case of intermediate uveitis with sub-Tenon's triamcinolone. The hole had persisted for 2 months after PPV with ILM peel and internal tamponade with 20% SF6 gas. They noted complete closure of hole within 1 week of sub-Tenon's injection. These reports suggest the potential role of steroids in the treatment of MH with associated intraocular inflammation.

The documentation of the mechanical plugging of the MH seen in our case [Figure 2]b and [Figure 2]c adds another dimension to the role of intravitreal steroids in the management of persistent MH, especially those associated with intraretinal cystic changes.

It seems quite evident, that apart from the anti-inflammatory role which brought down the retinal edema allowing the apposition of the inner retinal layers, the IVTA also helped by mechanically plugging the defect which was evident on fundus picture and OCT scans taken 1 week after injection [Figure 1]d and [Figure 2]a. Subsequent to the closure of the hole, a small plaque of the triamcinolone crystals persisted and was finally absorbed without causing any deleterious effect on the retinal photoreceptors [Figure 2]b and [Figure 2]c. The lack of toxicity of subretinal triamcinolone crystals has already been demonstrated.[8]

Similarly, Kumar et al. noted the presence of triamcinolone particles plugging a traumatic MH and inferred that it possibly delayed hole closure.[9] On the contrary, we believe that TA may have actually aided the hole closure in their case as it did in our case.

The TA deposits over the MH act like a temporary tamponade. The TA plugs the foveal defect and prevents further movement of vitreous fluid into the subretinal space. Once the fluid flux is halted, the retinal pigmentary epithelium (RPE) drives out the residual subretinal fluid aiding in the reposition of the retinal layers (neurosensory retina and RPE). In addition, the anti-inflammatory properties of TA allow a reduction in the cystoid spaces within the neurosensory retina. The mechanical advantages of TA act in synergism to its anti-inflammatory effects. The resolution of cystic changes and a simultaneous reduction in the retinal thickness produce a draw bridge-like effect allowing the approximation of the margins of dehiscence and opposes it to the underlying RPE.


  Conclusion Top


IVTA could be considered as a treatment option for the treatment of small persistent MH, especially in cases with small holes associated with intraretinal cystic changes. Further, studies with a larger number of patients would, however, be needed to substantiate this observation.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Patel R, Giridhar A, Gopalkrishnan M. Persistent macular hole: When to intervene. Kerala J Ophthalmol 2016;28:176.  Back to cited text no. 1
  [Full text]  
2.
Imai M, Gotoh T, Iijima H. Additional intravitreal gas injection in the early postoperative period for an unclosed macular hole treated with internal limiting membrane peeling. Retina 2005;25:158-61.  Back to cited text no. 2
    
3.
D'Souza MJ, Chaudhary V, Devenyi R. Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel. Br J Ophthalmol 2011;95:1564-7.  Back to cited text no. 3
    
4.
Leisser C, Hirnschall N, Döller B, Varsits R, Ullrich M, Kefer K, et al. Internal limiting membrane flap transposition for surgical repair of macular holes in primary surgery and in persistent macular holes. Eur J Ophthalmol 2017;28:225-8.  Back to cited text no. 4
    
5.
Tam A, Yan P, Gan N, Lam W. the current surgical management of large, recurrent, or persistent macular holes. Retina 2018;38:1263-1275.  Back to cited text no. 5
    
6.
Kwon Y, Chung H, Kim J, Yoon YH. Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye. Acta Ophthalmol 2009;87:111-2.  Back to cited text no. 6
    
7.
Shukla D, Dhawan A. Pharmacotherapeutic closure of a uveitic macular hole persisting after vitrectomy. Indian J Ophthalmol 2011;59:335-6.  Back to cited text no. 7
[PUBMED]  [Full text]  
8.
Liu H, Equi RA, Arai SI, Sadda S. Toxicity of subretinal triamcinolone. Invest Ophthalmol Vis Sci2002;43:2305.  Back to cited text no. 8
    
9.
Kumar A, Sinha S, Gupta A. Residual triamcinolone acetonide at macular hole after vitreous surgery. Indian J Ophthalmol 2010;58:232-4.  Back to cited text no. 9
[PUBMED]  [Full text]  


    Figures

  [Figure 1], [Figure 2], [Figure 3]


This article has been cited by
1 Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery
Yutong Li, Siyan Jin, Lijun Shi, Hecong Qin, Jinsong Zhao, Marco Lupidi
Journal of Ophthalmology. 2021; 2021: 1
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Case Report
Discussion
Conclusion
References
Article Figures

 Article Access Statistics
    Viewed1075    
    Printed15    
    Emailed0    
    PDF Downloaded107    
    Comments [Add]    
    Cited by others 1    

Recommend this journal